Lipoprotein storage disorders emerge as a heterogeneous group of genetic metabolic diseases. These conditions are characterized by the accumulation of abnormal lipoproteins, primarily within the cells, leading to a spectrum of clinical manifestations. The underlying mechanisms involve defects in the